Bowel (colorectal) cancer, Rectal cancer
Results
Phase 1
This study looked at cediranib and selumetinib for rectal cancer that has grown into the area around the rectum (back passage). It was supported by Cancer Research UK.
The trial was open for people to join between 2010 and 2012, and the research team published the results in 2019
Recruitment start: 1 September 2010
Recruitment end: 31 December 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Saunders
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
The Christie NHS Foundation Trust
This is Cancer Research UK trial number CRUKD/10/013.
Last reviewed: 16 Mar 2021
CRUK internal database number: 6816
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
